-

Optum Offers To Combine With Amedisys, Advancing Value-Based Care for Patients

Combination would accelerate seamless provision of value-based care in the home, improving patient outcomes and experiences

All-cash offer at $100 per share represents a superior proposal for Amedisys shareholders, with price certainty at a 26% premium over most recent share price

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Optum, a diversified health services company, has submitted an all-cash proposal to the Board of Directors of Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, to combine with Amedisys.

Patrick Conway, M.D., chief executive officer of Optum Care Solutions, said, “Amedisys’ commitment to quality and care innovation within the home, and the patient-first culture of its people, combined with Optum’s deep value-based care expertise can drive meaningful improvement in the health outcomes and experiences of more patients at lower costs, leading to continued growth.”

In-home care is provided by thousands of organizations nationwide, with no single participant having more than a single-digit percentage share, a core reason Optum is confident it can secure approval for the combination. Even with the numerous providers, demand for in-home care far exceeds available supply, creating the need for substantial investment in the sector to more fully serve patients and their families with compassionate, high quality care in the comfort of their own homes.

The $100 per share all-cash transaction provides full and certain value to Amedisys shareholders. The proposed transaction represents a 26% premium over Amedisys’ most recent closing share price and a premium of 29% to the unaffected Amedisys share price of $77.26. Optum’s proposal has no financing contingency or condition and does not require shareholder approval.

About Optum

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 220,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE: UNH). For more information, visit www.Optum.com.

Contacts

Investor Contact:
Zack Sopcak
952-936-7215
zack.sopcak@uhg.com

Media Contact
Aaron Albright
202-338-6403
aaron.albright@optum.com

Optum

NYSE:UNH

Release Summary
Optum offers to combine with Amedisys, a leading provider of home health, hospice and high-acuity care.
Release Versions

Contacts

Investor Contact:
Zack Sopcak
952-936-7215
zack.sopcak@uhg.com

Media Contact
Aaron Albright
202-338-6403
aaron.albright@optum.com

More News From Optum

Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model

--(BUSINESS WIRE)--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by dig...

Optum Rx to Modernize Pharmacy Payment Models

--(BUSINESS WIRE)--Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients. Effective immediately and with full implementation by January 2028, Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. This change will positively impact Optum Rx non-affiliated network pharmacies, including the more than 2...

Optum Rx Further Simplifies Consumer Access to Prescription Drugs

--(BUSINESS WIRE)--Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations. “Optum Rx is taking meaningful steps to simplify patient experiences and increase access to critical medications,” said Patrick Conway, M.D., chief executive officer, Optum Rx “These changes mean easier access to medicati...
Back to Newsroom